In the last three years, Novartis is the third MNC pharma company which has announced sale of a part of its business in India. Some of these restructuring are being done as part of the global readjustment being made at the parent companies level. The bigger question is whether after this restructuring will the MNC pharma stocks, which have been underperforming for quite some time, be able to make a comeback on the street or not. This answer to this question would depend on multiple factors. Right from the use of the sale proceeds to whether post restructuring focus would be on a 100 percent subsidiary or not. In both positive and negative cases, these stocks probably should be on watchlist as news flow around them increases in coming quarters. We take a look at 7 MNC pharma companies.
Top Gainers and Losers Today : The Sensex gained 535.15 points, or 0.74, to settle at 72623.09, while the Nifty gained 162.4 points, or 0.74, to close at 22055.05.
​Some of their top picks in January included IndusInd Bank, Bank of India, Divis Laboratories, GlaxoSmithKline Pharmaceuticals, Aditya Birla Capital, Unichem Laboratories and Ipca Laboratories.
Uinta County Herald | 2-14-2024 Uinta County Herald legal notices uintacountyherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from uintacountyherald.com Daily Mail and Mail on Sunday newspapers.